Neurofibromatosis Type 1
Rare Disease·MeSH: Neurofibromatosis 1
Prevalence
30.0 / 100K
6 drugs in development·2 companies·8 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Compare drugs
Frequently asked questions
How many drugs are in development for Neurofibromatosis Type 1?
BioSniper tracks 6 drugs in development for Neurofibromatosis Type 1 across 2 companies.
How many clinical trials target Neurofibromatosis Type 1?
There are 8 clinical trials targeting Neurofibromatosis Type 1 tracked by BioSniper.
What is the prevalence of Neurofibromatosis Type 1?
The estimated prevalence of Neurofibromatosis Type 1 is approximately 30.0 per 100,000 population.
Deep-dive into Neurofibromatosis Type 1
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis